英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Oxiconazole nitrate |
|
64211-46-7 |
詳細(xì)
|
RS 25344 hydrochloride |
|
152815-28-6 |
詳細(xì)
|
Benzamide, N-hydroxy-4-[[[[(2-methoxyphenyl)amino]carbonyl]amino]methyl]- |
|
1454902-97-6 |
詳細(xì)
|
2-Methyl-5-(1-methylethyl)-2,5-cyclohexadiene-1,4-dione 1-[O-(2-methylbenzoyl)oxime |
|
321688-88-4 |
詳細(xì)
|
PQR-530 |
|
1927857-61-1 |
詳細(xì)
|
TOCAINIDE |
|
41708-72-9 |
詳細(xì)
|
N2,N4-bis(2-methyl-1H-indol-5-yl)pyrimidine-2,4-diamine |
|
1071098-42-4 |
詳細(xì)
|
1-(3-Nitrophenyl)-3-(4-pyridinylmethyl)-pyrido[2,3-d]pyrimidine-2,3-(1H,3H)-dionehydrochloride |
|
152814-89-6 |
詳細(xì)
|
2-Pyridinamine, 5,6-bis(4-methoxy-3-methylphenyl)- |
|
2306039-66-5 |
詳細(xì)
|
NS3861 >=98% (HPLC) |
|
216853-59-7 |
詳細(xì)
|
Paquinimod |
|
248282-01-1 |
詳細(xì)
|
KX2-391 |
|
897016-82-9 |
詳細(xì)
|
(1R,2R)-2-fluorocyclopropanecarboxylic acid |
(1R,2R)-2-氟環(huán)丙烷羧酸 |
127199-13-7 |
詳細(xì)
|
CC-90009 |
|
1860875-51-9 |
詳細(xì)
|
(R)-N- (4-(chlorodifluoromethoxy)phenyl)- 6-(3- hydroxypyrrolidin-1- yl)-5- (1H-pyrazol- 5-yl)nicotinamide |
|
1492952-76-7 |
詳細(xì)
|
GSK778 |
|
2451862-42-1 |
詳細(xì)
|
3-N-BUTYLPHTHALIDE |
|
6066-49-5 |
詳細(xì)
|
N,N-diethyl-2-((6-methylpyridin-2-yl)methylene)hydrazinecarbothioamide |
N,N-二乙基-2-((6-甲基吡啶-2-基)亞甲基)肼基硫酰胺 |
210700-64-4 |
詳細(xì)
|
4-Pyrimidinamine, N-(4,4-difluorocyclohexyl)-2-(3-methyl-1H-pyrazol-1-yl)-6-(4-morpholinyl)- |
|
2167246-24-2 |
詳細(xì)
|
Butamirate Impurity 1 |
|
92321-53-4 |
詳細(xì)
|
10-methyl-9-(phenoxycarbonyl) Acridinium (trifluoromethylsulfonate) |
9-[(苯氧基)羰基]-10甲基三氟甲酰胺磺酸鹽 |
161006-14-0 |
詳細(xì)
|
(4-benzylpiperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone |
(4-芐基哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮 |
906258-48-8 |
詳細(xì)
|
Parimifasor |
|
1796641-10-5 |
詳細(xì)
|
Tryptophan, N-indol-3-ylacetyl- (6CI) |
N-(3-吲哚乙?;?-L-色氨酸 |
57105-53-0 |
詳細(xì)
|
RBPJ Inhibitor-1(RIN1) |
|
|
詳細(xì)
|
(4-(4-methoxyphenyl)piperazin-1-yl)(2-(4-methylpiperidin-1-yl)benzo[d]thiazol-6-yl)methanone |
(4-(4-甲氧基苯基)哌嗪-1-基)(2-(4-甲基哌啶-1-基)苯并[d]噻唑-6-基)甲酮 |
906258-69-3 |
詳細(xì)
|
1-Pentanone, 1-(1,3,4,9-tetrahydro-1-phenyl-2H-pyrido[3,4-b]indol-2-yl)- |
2,3,4,9-四氫-2-(1-氧代戊基)-1-苯基-1H-吡啶并[3,4-b]吲哚 |
334939-35-4 |
詳細(xì)
|
Benzeneacetonitrile, 4-cyano-α-[[4-[[2-(dimethylamino)ethyl]methylamino]phenyl]methylene]- |
|
2530161-67-0 |
詳細(xì)
|
(S)-2-Amino-N1-benzhydrylpentanediamide |
(S)-2-氨基-N1-苯并二胺 |
2429878-52-2 |
詳細(xì)
|
N-(2-Chloro-6-methylphenyl)-N'-4-pyridinylurea |
|
97627-24-2 |
詳細(xì)
|
N-OMEGA-HYDROXYL-NOR-L-ARGININE, DIHYDROCHLORIDE |
|
291758-32-2 |
詳細(xì)
|
KB3022 |
|
101001-34-7 |
詳細(xì)
|
2-(3,4-Dihydroxy-benzylidene)-benzofuran-3-one, Sphingosine Kinase Inhibitor V |
|
24418-86-8 |
詳細(xì)
|
Ribavirin Related Compound A (15 mg) (1-beta-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxylic acid) |
|
39925-19-4 |
詳細(xì)
|
2-Chloro-N-[(9H-fluoren-9-ylamino)carbonyl]-6-fluorobenzamide |
|
1186372-20-2 |
詳細(xì)
|
MYCMI-6 |
|
681282-09-7 |
詳細(xì)
|
ML-180 |
|
863588-32-3 |
詳細(xì)
|
Apcin |
|
300815-04-7 |
詳細(xì)
|
STAT3-IN-1 |
|
2059952-75-7 |
詳細(xì)
|
A 1120 |
|
1152782-19-8 |
詳細(xì)
|
CLONIDINE RELATED COMPOUND A (25 MG) (ACET-YLCLONIDINE) |
|
54707-71-0 |
詳細(xì)
|
TH1020 |
|
1841460-82-9 |
詳細(xì)
|
N-((S)-1-(4-((S)-2-(2,4-dichlorophenylsulfonaMido)-3-hydroxypropanoyl)piperazin-1-yl)-4-Methyl-1-oxopentan-2-yl)benzo[b]thiophene-2-carboxaMide |
|
942206-85-1 |
詳細(xì)
|
N,N'-[Sulfonylbis(1,4-phenylene)]bis(chloroacetamide) |
|
17328-16-4 |
詳細(xì)
|
MF-438 |
|
921605-87-0 |
詳細(xì)
|
MIT 9952-53 |
|
321673-30-7 |
詳細(xì)
|
GS143 |
|
916232-21-8 |
詳細(xì)
|
2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE |
|
186689-07-6 |
詳細(xì)
|
1H-Benzotriazole-7-carboxylic acid, 1-methyl-5-(2'-methyl[1,1'-biphenyl]-4-yl)- |
|
1623416-31-8 |
詳細(xì)
|
N'-((6-Methylpyridin-2-yl)methylene)pyrrolidine-1-carbothiohydrazide |
N'-((6-甲基吡啶-2-基)亞甲基)吡咯烷-1-硫代肼 |
907549-72-8 |
詳細(xì)
|
Benzonitrile, 3-[[(1S,2S,3R)-2,3-difluoro-2,3-dihydro-1-hydroxy-7-(methylsulfonyl)-1H-inden-4-yl]oxy]-5-fluoro- |
|
1672668-24-4 |
詳細(xì)
|
AC710 |
|
1351522-04-7 |
詳細(xì)
|
CHR-6494 |
|
1333377-65-3 |
詳細(xì)
|
5-(3-(1-naphthoyl)-1H-indol-1-yl)pentanenitrile |
|
335161-19-8 |
詳細(xì)
|
3-(3-Bromo-2-thienyl)-8-methyl-8-azabicyclo[3.2.1]oct-2-ene fumarate |
|
216853-60-0 |
詳細(xì)
|
N-[4-(2-BROMO-4,5-DIFLUOROPHENOXY)PHENYL]-L-ASPARAGINE |
|
868359-05-1 |
詳細(xì)
|
BI 2536 |
|
755038-02-9 |
詳細(xì)
|
CC-885 |
|
1010100-07-8 |
詳細(xì)
|
4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-[4-(2H-tetrazol-5-yl)butyl]-piperidine |
|
162640-98-4 |
詳細(xì)
|
ALW-II-41-27 |
|
1186206-79-0 |
詳細(xì)
|
CDKI-73 |
|
1421693-22-2 |
詳細(xì)
|
CHR 6494 trifluoroacetate |
|
1458630-17-5 |
詳細(xì)
|
MP07-66 |
|
1938056-90-6 |
詳細(xì)
|
1-METHYL-4-[THIOXANTHEN-9-YLIDENE]PIPERIDINE MALEATE SALT |
|
13187-06-9 |
詳細(xì)
|
N-0437 |
|
92206-54-7 |
詳細(xì)
|
1-(1-Methylethyl)-3-(2-phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine |
|
1357349-91-7 |
詳細(xì)
|
N-(1,2-Dimethyl-1H-benzo[d]imidazol-5-yl)-1-(3-fluorobenzyl)-1H-pyrrolo[3,2-c]pyridine-2-carboxamide |
N-(1,2-二甲基-1H-苯并咪唑-5-基)-1-[(3-氟苯基)甲基]-1H-吡咯[3,2-c]吡啶-2-羧酰胺 |
920978-76-3 |
詳細(xì)
|
Parsaclisib |
|
1426698-88-5 |
詳細(xì)
|
MLI-2 |
|
1627091-47-7 |
詳細(xì)
|
BDTX-189 |
|
2414572-47-5 |
詳細(xì)
|
STM2457 |
|
2499663-01-1 |
詳細(xì)
|
LMK-235 |
|
1418033-25-6 |
詳細(xì)
|
BETd-260 |
|
2093388-62-4 |
詳細(xì)
|
MYF-01-37 |
|
2416417-65-5 |
詳細(xì)
|
MBX2329 |
|
1438272-42-4 |
詳細(xì)
|
Verubulin |
|
827031-83-4 |
詳細(xì)
|
GOT1 inhibitor 2c |
|
732973-87-4 |
詳細(xì)
|
KM91104 |
|
304481-60-5 |
詳細(xì)
|
Cadralazine |
|
64241-34-5 |
詳細(xì)
|
2-methyl-5-nitroimidazol-1-ylacetic acid |
|
1010-93-1 |
詳細(xì)
|
ZL006 |
化合物ZL006 |
1181226-02-7 |
詳細(xì)
|
TMEM16AInhibitorsRevealTMEM16A(T16Ainh-A01) |
|
552309-42-9 |
詳細(xì)
|
1-(5-Chloro-2-hydroxyphenyl)-ethanone 2-(2,4,6-trichlorophenyl)hydrazone |
|
219315-22-7 |
詳細(xì)
|
1,6-dimethyl-3-phenylpyrimido[5,4-e][1,2,4]triazine-5,7-dione |
|
32502-63-9 |
詳細(xì)
|
Metronidazole-Impurity-11 |
|
1410831-12-7 |
詳細(xì)
|
2,4-Thiazolidinedione, 5-[[5-[6-(4-acetyl-1-piperazinyl)-3-nitro-2-pyridinyl]-2-fluorophenyl]methylene]- |
|
853953-65-8 |
詳細(xì)
|
ARP 100 |
|
704888-90-4 |
詳細(xì)
|
CYCLIZINE HCL |
|
82-92-8 |
詳細(xì)
|
Benzeneacetamide, N-[3-[(3,4-dihydro-2,4-dioxo-3-propylthieno[3,2-d]pyrimidin-1(2H)-yl)methyl]phenyl]- |
|
2098776-03-3 |
詳細(xì)
|
(E)-(5-nitrofuran-2-yl)methylideneamino]urea |
|
112574-44-4 |
詳細(xì)
|
4(3H)-Quinazolinone, 8-fluoro-3-[4-(4-fluorophenoxy)phenyl]-2-(4-methyl-1-piperazinyl)- |
|
2314467-59-7 |
詳細(xì)
|
4-KETO ALL-TRANS-RETINOIC ACID METHYL ESTER |
|
38030-58-9 |
詳細(xì)
|
Bis(trans-cinnamic acid)anhydride |
|
21947-71-7 |
詳細(xì)
|
EG1 (Pax2 inhibitor EG1) |
|
693241-54-2 |
詳細(xì)
|
KI-7 |
|
1489263-00-4 |
詳細(xì)
|
EGFR-IN-5 |
|
2225887-26-1 |
詳細(xì)
|
2-(4-fluorophenyl)-3-(isopropyl(methyl)amino)quinoxaline-6-carboxylic acid |
|
1268863-35-9 |
詳細(xì)
|
Ethanone, 2-chloro-1-(3-indolyl)- |
|
28755-03-5 |
詳細(xì)
|
N-(2-CHLOROETHYL)-N-ETHYL-2-BROMOBENZYLAMINE HYDROCHLORIDE |
|
40616-75-9 |
詳細(xì)
|
(S)-(+)-2-METHYLBUTYL P-[(P-METHOXYBENZYLIDENE)AMINO]CINNAMATE |
(S)-2-甲基丁基3-(4-((4-甲氧基亞芐基)氨基)苯基)丙烯酸酯 |
24140-30-5 |
詳細(xì)
|